Canine adipose‐derived stromal cell viability following exposure to synovial fluid from osteoarthritic joints. Issue 1 (24th July 2015)

• Record Type: Journal Article
• Authors: Kiefer, Kristina M.; O'Brien, Timothy D.; Pluhar, Elizabeth G.; Conzemius, Michael
• Is Part Of: Veterinary record open. Volume 2:Issue 1(2015)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2015-07-24
• Subjects: Arthritis -- Dogs -- Stem cell therapy; Veterinary medicine -- Periodicals; Veterinary medicine -- Research -- Periodicals; 636.08905
• DOI: 10.1136/vetreco-2014-000063
• Languages: English
• ISSNs: 2052-6113

Abstract

Abstract : Introduction: Stem cell therapy used in clinical application of osteoarthritis in veterinary medicine typically involves intra‐articular injection of the cells, however the effect of an osteoarthritic environment on the fate of the cells has not been investigated. Aims and Objectives: Assess the viability of adipose derived stromal cells following exposure to osteoarthritic joint fluid. Materials and Methods: Adipose derived stromal cells (ASCs) were derived from falciform adipose tissue of five adult dogs, and osteoarthritic synovial fluid (SF) was obtained from ten patients undergoing surgical intervention on orthopedic diseases with secondary osteoarthritis. Normal synovial fluid was obtained from seven adult dogs from an unrelated study. ASCs were exposed to the following treatment conditions: culture medium, normal SF, osteoarthritic SF, or serial dilutions of 1:1 to 1:10 of osteoarthritic SF with media. Cells were then harvested and assessed for viability using trypan blue dye exclusion. Results: There was no significant difference in the viability of cells in culture medium or normal SF. Significant differences were found between cells exposed to any concentration of osteoarthritic SF and normal SF and between cells exposed to undiluted osteoarthritic SF and all serial dilutions. Subsequent dilutions reduced cytotoxicity. Conclusions: Osteoarthritic synovial fluid in this ex vivo experiment is cytotoxic to ASCs, when compared with normal synovial fluid. Current practice of direct injection of ASCs into osteoarthritic joints should be re‐evaluated to determine if alternative means of administration may be more effective.